Can Mycophenolate Mofetil be Tapered Safely in MG. A Retrospective, Multicenter Analysis

episode

American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Russia’s New Drone Threat Raises Alarms in Ukraine 21 min · 27 Sep 2026 · The MeidasTouch Podcast

FULL SHOW: Evict My House Guest Awkward, Whatcha Doin’ at Oktoberfest + Prison Prank (9/22/26) 55 min · 27 Sep 2026 · Brooke and Jeffrey: Second Date Update

The Inherited Mindset: Firing Your Family’s Financial Beliefs 3 min · 27 Sep 2026 · The Level Up Podcast w/ Paul Alex

The Rise of the AI Moderates 32 min · 27 Sep 2026 · The AI Daily Brief: Artificial Intelligence News and Analysis

NPR News: 09-27-2026 7AM EDT 5 min · 27 Sep 2026 · NPR News Now

7AM ET 09/27/2026 Newscast 3 min · 27 Sep 2026 · Fox News Hourly Update

Report any issue

Source

Recorded24 Feb 2016

Publisheranchor.fm ↗

Handlerec:820527

Show notes

Dr. Justin Willer interviews Dr. Lisa Hobson Webb about her Muscle and Nerve article on safely tapering mycophenolate mofetil in myasthenia gravis patients. MMF is frequently used to treat patients with MG but there is little information to guide clinicians on the safety of reducing the dose in well-controlled patients. Discussion includes standard dosages, determining clinical response to MMF and suggested goals in tapering MMF. Muscle Nerve. 2015 Aug;52:211-5. doi: 10.1002 mus.24694. Epub 2015 Jun 18.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in